Antimalarial drugs combinations for malaria prevention and treatment;Pratique des combinaisons d'antipaludiques pour le traitement et la prévention du paludisme

Medecine et Maladies Infectieuses

Volumn 31, Issue 12, 2001, Pages 693-704

  Bourgeade, A ^a   Nosny, Y ^a   Delmont, J ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Antimalarial drugs; Drug association; Malaria; Prevention; Treatment

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; AZITHROMYCIN; CHLOROQUINE; CLINDAMYCIN; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; FANSIDAR; FANSIMEF; HALOFANTRINE; MALOPRIM; MEFLOQUINE; METAKELFIN; PRIMAQUINE; PROGUANIL; PYRONARIDINE; QUINIMAX; QUININE; SPIRAMYCIN; TAFENOQUINE; TETRACYCLINE; TOTAQUINE;

CHEMOPROPHYLAXIS; DRUG EFFICACY; HUMAN; MALARIA; MONOTHERAPY; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RELAPSE; REVIEW;

EID: 0035215957     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(01)00294-3     Document Type: Review

References (90)

1. Traitement du paludisme: Prévenir les résistances par les associations d'antipaludiques
2. Combination therapy for malaria in Africa: Hype or hope
3. Activity of a combination of three cinchoina alkaloids against Plasmodium falciparum
4. A combination of quinine, quinidine and cinchonine (LA40221) in the treatment of chloroquine resistant falciparum malaria in Thailand: Two double blind trials
5. Combination of the antibiotics erythromycine and tetracycline with the standard antimalarial against Plasmodium falciparum in vitro
6. Drug synergism against Plasmodium falciparum in vitro
7. Tetracycline treatment of chloroquine resistant falciparum malaria in Thailand
8. Quinine tetracycline and quinine Bactrim treatment of acute falciparum malaria in Thailand
9. Plasma quinine levels in patients with falciparum malaria when given alone or in combination with tetracycline with or without primaquine
10. The current status of drug resistant malaria
11. Efficacy of quininetetracycline for acute uncomplicated falciparum malaria in Thailand
12. Failure of chloroquineerythromycin combination in treatment of chloroquine resistant falciparum malaria in eastern Thailand
13. Spiramycine does not potentiate quinine treatment in falciparum malaria pregnancy
14. Clindamycin is effective against Plasmodium falciparum but not against P. vivax in mixed infections
15. Antimalarial effects of clindamycin in man
16. Evaluation of clindamycin in combination with quinine against multidrug resistant strains of Plasmodium falciparum
17. Therapeutic responses to quinine and clindamycine in multidrug-resistant falciparum malaria
18. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in chidren from Gabon
19. Controlled trial of 3-day quinine-clindamycin versus 7-day quinine treatment for adult travelers with uncomplicated falciparum malaria imported from the tropics
20. A single dose of intramuscular sulfadoxy-pyrimethamine as an adunct to quinine in the treatment of severe malaria: Pharmacokinetic and efficacy
21. Therapeutics effects of chloroquine in combination with quinine in uncomplicated falciparum malaria
22. Prevention of drug resistance in rodent malaria by the use of drug mixtures
23. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: A randomised trial
24. The pharmacokinetics and activation of proguanil in man: Consequences of variability in drug metabolism
25. Failure of chloroquineerythromycin and chloroquine-tetracycline combinations in treatment of chloroquine-resistant falciparum malaria in eastern Thailand
26. Intravenous amodiaquine and oral amodiaquine-erythromycin in the treatment of chloroquine-resistant falciparum malaria
27. Failure of large dose erythromycin in combination with a standard dose of chloroquine or quinine in the treatment of human falciparum malaria
28. Failure of erythromycin to improve chloroquine treatment of Plasmodium falciparum in Kenya
29. Synergy of four macrolide antibiotics with chloroquine against chloroquine-resistant Plasmodium falciparum
30. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine
31. La primaquine (revue générale)
32. Comparative efficacy of chloroquine plus chlorpheniramine and halofantrine in acute uncomplicated falciparum malaria in Nigerian children
33. Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxinepyrimethamine for treatment of acute, uncomplicated, falciparum malaria in children
34. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine
35. Is reversal of chloroquine resistance ready for the clinic?
36. Malaria in the Australian army in South Viet-Nam: Successful use of proguanil-dapsone combination for chemoprophylaxis of chloroquine resistant falciparum malaria
37. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand
38. Chlorproguanil-dapsone for the treatment of non severe falciparum malaria in Kenya - A pilot study
39. Research in new antimalarial drugs and use of drugs in combination at the Bangkok hospital for tropical diseases
40. The inhibitory effect of a drug combination on the development of mefloquine resistance to Plasmodium berghei
41. Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand
42. Minimal effective dose of mefloquine/sulfadoxine/pyrimethamine in mild Plasmodium falciparum malaria
43. Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine-pyrimethamine compared with equivalent doses of sulfadoxine-pyrimethamine or mefloquine alone
44. In vitro response of Plasmodium falciparum to atovaquone and correlation with other antimalarials: Comparison between African and Asian strains
45. Clinical studies of atovaquone alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand
46. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro
47. Malarone (atovaquone and proguanil hydrochloride): A review of its clinical development for treatment of malaria
48. Efficacy and pharmacokinetics of atovaquone and proguanil in children with multi-drugresistant Plasmodium falciparum malaria
49. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pytimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines
50. Atovaquone and proguanil for Plasmodium falciparum malaria
51. Atovaquone and proguanil for the treatment of malaria in Brazil
52. Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: A randomized comparative trial
53. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria
54. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: A randomised, double-blind study
55. Prophylactic effect of malarone against malaria: All good news?
56. Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in Thailand
57. The activity of triple combination of antifolates biguanides with and without folinic acid against Plasmodium falciparum in vitro
58. Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia
59. Clinical pharmacocinetics and pharmacodynamics of artemisinin and derivative
60. In vitro sensitivities of Plasmodium falciparum to eight antimalarial in China-Myanmar and China-Lao PDR border areas
61. Clinical trial of artesunate and artemether on multiresistant falciparum malaria in Thailand: A preliminary report
62. Overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam
63. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro
64. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria
65. Two doses of artemether/mefloquine or artesunate/mefloquine combination for multidrug resistant falciparum malaria
66. Treatment of multidrug resistant Plasmodium falciparum malaria with 3-day artesunate mefloquine combination
67. Artesunate-mefloquine treatment in multidrug resistant falciparum malaria
68. Artesunate versus artemether in combination with mefloquine for the treatment of multi-resistant falciparum malaria
69. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study
70. A comparative clinical trial of sequential treatment of severe malaria with artesunate suppository followed by mefloquine in Thailand
71. Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand
72. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: A double-blind, randomised, controlled trial
73. Randomised trial of mefloquine-doxycycline and artesunate doxycycline for treatment of acute uncomplicated falciparum malaria
74. Randomised controlled trial of artesunate plus tetracycline versus treatment standard (quinine plus tetracycline) for uncomplicated Plasmodium falciparum malaria in Brazil
75. Activity of artemether-azithromycin versus artemetherdoxycycline in the treatment of multiple drug resistant falciparum malaria
76. Phase II trial in China of a new and rapidly-acting and effective antimalarial CGP 56697 for the treatment of Plasmodium falciparum malaria
77. A randomised, double-blind, comparative trial of a new oral combination artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand
78. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria
79. Dose-finding study of the efficacy of fixed-combination artemether/Lumefantrine for the treatment of multidrug-resistant Plasmodium falciparum malaria in Thailand
80. A randomised, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India
81. A randomised controlled trial of artemether/benflumetol, a new antimalarial and pyrimethaminesulfadoxine in treatment of uncomplicated falciparum malaria in African children
82. Efficacy and safety of CGP 56697 (artemether-benflumetol) compared with chloroquine to treat acute falciparum malaria in tanzanian childrens aged 1-5 years
83. Randomised comparison of artesunate-benflumetol and artesunate-mefloquine in treatment of multidrug resistant Plasmodium falciparum malaria
84. Artemether - Lumefantrine for the treatment of multidrug-resistant falciparum malaria
85. The comparative efficacity and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the tropics to the Netherlands and France
86. A 5-years surveillance of sensitivity in vitro of Plasmodium falciparum to pyronaridine-sulfadoxinepyrimethamine in Diachio area, Hainan Province
87. Studies on a new antimalarial compound: Pyronaridine
88. Recent military experience with malaria chemoprophylaxis
89. Randomised dose-ranging study of the safety and efficacy of WR238605 (tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand
90. WR 238605, chloroquine and their combinations as blood schizonticides against chloroquine resistant strain of Plasmodium vivax in aotus monkey